1. Home >
  2. M&A >
  3. Joint Venture >
  4. United States >
  5. Florida >
  6. Viatris and Watson Pharmaceuticals Acquire Somerset Pharmaceuticals

Joint Venture • Life Science

Viatris and Watson Pharmaceuticals Acquire Somerset Pharmaceuticals

On January 1, 1988, Viatris and Watson Pharmaceuticals acquired life science company Somerset Pharmaceuticals

Acquisition Context
  • This is Viatris’ 1st and Watson Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Viatris’ 1st and Watson Pharmaceuticals’ 1st transaction in the United States.
  • This is Viatris’ 1st and Watson Pharmaceuticals’ 1st transaction in Florida.

Explore All 25 Joint Venture Life Science Deals - Search the Database Free


M&A Deal Summary
Date January 1, 1988
Target Somerset Pharmaceuticals
Sector Life Science
Buyer(s) Viatris
Watson Pharmaceuticals
Deal Type Joint Venture

Target Company

Somerset Pharmaceuticals

Tampa,, Florida, United States
Somerset, a proprietary research and development company,Somerset developed EMSAM(R), a transdermal patch for the treatment of major depressive disorder, currently marketed in the United States by Bristol-Myers Squibb.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyers Overview 2

Buyer

Viatris

Canonsburg, Pennsylvania, United States
Category Company
Founded 1961
Sector Life Science
Employees32,000
Revenue 14.7B USD (2024)
DESCRIPTION

Viatris is a generic and specialty pharmaceutical company. Viatris offers the industry's broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Viatris was founded in 1961 and is based in Canonsburg, Pennsylvania.

Deal Context for Buyer #
Overall 1 of 14
Sector: Life Science 1 of 11
Type: Joint Venture 1 of 1
State: Florida 1 of 2
Country: United States 1 of 6
Year: 1988 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-08-28 Mylan Laboratories

Secunderabad, India

Mylan Laboratories Limited (Mylan Labs), a subsidiary of U.S.-based Mylan Inc. (Nasdaq: MYL), is one of the world’s largest manufacturers and suppliers of active pharmaceutical ingredients (APIs). Based in Hyderabad, India, Mylan Labs offers more than 150 APIs and intermediates to customers in more than 80 countries across a wide range of therapeutic categories.

Buy -
Buyer

Watson Pharmaceuticals

Florham Park, New Jersey, United States
Category Company
Founded 1931
Sector Medical Products
Employees1,325
DESCRIPTION

Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

Deal Context for Buyer #
Overall 1 of 9
Sector: Life Science 1 of 5
Type: Joint Venture 1 of 1
State: Florida 1 of 1
Country: United States 1 of 2
Year: 1988 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-22 Fiorinal and Fioricet product lines

United States

The Fioricet(R) and Fiorinal(R) lines of products are indicated for the treatment of tension headaches.

Buy $178M

Explore Related M&A Activity

Life Science M&A - Joint Venture M&A Deals - Florida M&A - United States M&A

Mergr

Solution for

Product

Company

Legal